Scinovex
article Open AccessTop 10% cited

From ATP to AZD6140: The discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis

Bioorganic & Medicinal Chemistry Letters · 2007 · Vol. 17(21) · pp. 6013–6018
Brian SpringthorpeA. S. BaileyPatrick BartonTimothy N. BirkinshawRoger V. BonnertRoger C. BrownDavid A. ChapmanJohn DixonSimon D. GuileRobert G. HumphriesSimon F. HuntFrancis InceAnthony H. IngallIan P. KirkPaul D. LeesonPaul LeffRichard J. LewisBarrie MartinDermot F. McGinnityMichael P. MortimoreStuart W. PaineGarry PairaudeauAnil S. PatelAaron RigbyRobert J. RileyBarry TeobaldWendy TomlinsonPeter J. H. WebbornPaul Willis
Antiplatelet Therapy and Cardiovascular DiseasesSynthesis of β-Lactam CompoundsAcute Myocardial Infarction ResearchChemistryP2Y12AntagonistPharmacologyPurineReceptorAdenosine triphosphateThrombosisBiochemistryStereochemistry

MeSH terms

TicagrelorAdenosineAdenosine TriphosphateAdministration, OralAnimalsHumansMembrane ProteinsThrombosisPurinergic P2 Receptor AntagonistsReceptors, Purinergic P2Y12
Citations
233
FWCI
6.24
field-weighted impact
References
15
Percentile
97%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.